EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

The global telemedicine market increased over 8% from 2022 to 2023, exceeding $94bn. Forecasts suggest the market could reach over $286bn by 2028.1

Leveraging Artificial Intelligence

AI could be the missing link to achieve transformative digitization in the Health Care sector. In the U.S. alone, it's estimated that AI could save as much as 10% of annual health care spending.2

Expanding Use Cases

Following success in diabetic monitoring, wearables are expanding into cardiovascular care. The potential market could be enormous, as an estimated 33mm people have atrial fibrillation3 and some 1.28bn adults have hypertension.4

1Fortune Business Insights, Jul 2023
2National Bureau of Economic Research, Jan 2023
3Frontiers in Public Health, Jun 2023
4World Health Organization, Mar 2023

Key Information As of 03/01/24

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $62.78 million
NAV $9.58

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 03/01/24

Ticker EDOC
B3 Trading Code BEDC39
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 6,550,000
Number of Holdings 37
30-Day Median Bid-Ask Spread 0.95%

Distributions As of 03/01/24

30-Day SEC Yield 0.08%
Distribution Frequency Semi-Annually

ETF Prices As of 03/01/24

NAV $9.58 Daily Change $0.03 0.31%
Market Price $9.55 Daily Change $0.04 0.42%

Performance History

Cumulative Returns (as of 02/29/24)
1 Month 6 Months YTD 12 Months 24 Months Since Inception Inception Date
Return EDOC 1.92% -7.75% -6.00% -18.72% -35.38% -37.27% 07/29/20
Returns (as of 02/29/24)
Return EDOC Return Index
Since Inception -37.27% -36.26%
12 Months -19.04% -18.61%
24 Months -35.60% -35.09%
Last 60 Trading Days 4.46% 4.60%
Last 75 Trading Days 17.00% 17.26%
Monthly Returns (through 02/29/24)
Return EDOC Return Index
Mar 2024 0.00% 0.00%
Feb 2024 1.92% 1.92%
Jan 2024 -7.79% -7.67%
Dec 2023 13.52% 13.51%
Nov 2023 9.42% 9.52%
Oct 2023 -10.99% -11.00%
Sep 2023 -11.21% -11.15%
Aug 2023 -13.97% -13.91%
Jul 2023 3.18% 3.21%
Jun 2023 4.66% 4.70%
May 2023 -5.45% -5.40%
Apr 2023 -0.09% -0.03%
Mar 2023 0.33% 0.40%
Feb 2023 -6.01% -6.31%
Jan 2023 7.01% 7.03%
Dec 2022 -4.53% -4.47%
Nov 2022 4.52% 4.60%
Oct 2022 3.35% 3.84%
Sep 2022 -7.68% -8.05%
Aug 2022 -3.76% -3.66%
Jul 2022 10.41% 10.44%
Jun 2022 -3.27% -3.25%
May 2022 -4.34% -4.23%
Apr 2022 -15.79% -15.77%
Mar 2022 0.34% 0.37%

Total returns take into account management, administration and fees and other costs automatically deducted from the fund's assets. Before investing, you may read the prospectus in the “FEES AND EXPENSES” section for more details.

NAV & Index Chart

Top Holdings As of 03/01/24

Net Assets (%) Ticker Name Country SEDOL Market Price ($) Shares Held Market Value ($)
5.72 IRTC IRHYTHM TECHNOLOGIES INC United States BYT4ST5 120.52 29,789 3,590,170.28
5.50 MASI MASIMO CORP United States B1YWR63 126.49 27,292 3,452,165.08
5.17 DXCM DEXCOM INC United States B0796X4 121.74 26,641 3,243,275.34
4.81 A AGILENT TECHNOLOGIES INC United States 2520153 139.06 21,732 3,022,051.92
4.61 DOCS DOXIMITY INC-CLASS A United States BMD22Y4 28.05 103,268 2,896,667.40
4.53 TWST TWIST BIOSCIENCE CORP United States BGKG6G7 38.89 73,174 2,845,736.86
4.44 OSCR OSCAR HEALTH -A United States BKY83Q6 16.58 167,968 2,784,909.44
4.41 ILMN ILLUMINA INC United States 2613990 140.50 19,724 2,771,222.00
4.41 RMD AU RESMED INC-CDI Australia 6221667 17.46 158,577 2,768,148.64
4.36 RCM R1 RCM INC United States BP2S437 14.00 195,399 2,735,586.00
3.95 LH LABORATORY CP United States 2586122 218.00 11,366 2,477,788.00
3.75 TNDM TANDEM DIABETES CARE INC United States BF3W461 27.58 85,379 2,354,752.82
3.73 HIMS HIMS & HERS HEALTH INC United States BN46048 13.12 178,467 2,341,487.04
3.63 VCYT VERACYTE INC United States BFTWZY0 24.00 94,901 2,277,624.00
3.62 PRVA PRIVIA HEALTH GROUP INC United States BMDP209 22.32 101,948 2,275,479.36
3.13 6618 HK JD HEALTH Hong Kong BMW8R04 3.77 520,750 1,962,207.82
3.08 TDOC TELADOC HEALTH INC United States BYQRFY1 15.00 129,053 1,935,795.00
2.81 241 HK ALIBABA HEALTH Hong Kong BRXVS60 0.44 3,995,100 1,765,620.90
2.76 AMN AMN HEALTHCARE United States 2813552 56.81 30,501 1,732,761.81
2.72 PHR PHREESIA INC United States BKF9DQ8 24.98 68,413 1,708,956.74
2.64 PACB PACIFIC BIOSCIEN United States B4N8MH9 5.19 319,791 1,659,715.29
2.46 OMCL OMNICELL INC United States 2789523 26.36 58,510 1,542,323.60
1.76 COP GR COMPUGROUP MEDIC Germany BMY7CH1 31.47 35,157 1,106,263.24
1.66 1833 HK PING AN HEALTHCA Hong Kong BDRYVB3 1.53 680,400 1,042,891.81
1.66 4483 JP JMDC INC Japan BK7C5Q9 25.35 41,020 1,039,674.27
1.43 4480 JP MEDLEY INC Japan BK93ZN7 33.71 26,625 897,402.16
1.30 GDRX GOODRX HOLDIN-A United States BMTVQT8 8.35 98,068 818,867.80
1.16 LFST LIFESTANCE HEALT United States BN0TRB7 7.79 93,523 728,076.56
0.85 DH DEFINITIVE HEALT United States BMGSDK2 8.97 59,333 532,217.01
0.77 DCGO DOCGO INC United States BKP4P23 4.13 117,318 484,523.34
0.61 SENS SENSEONICS HOLDINGS INC United States BYQNYR5 0.63 610,604 383,764.61
0.57 228760 KS GENOMICTREE INC Republic Of Korea BYNNYF6 16.48 21,782 359,052.94
0.56 SHCR SHARECARE INC United States BJL95B4 0.95 368,478 350,385.73
0.49 AMWL AMERICAN WELL -A United States BN0SDK5 1.06 289,301 306,659.06
0.32 ME 23ANDME HOLDIN-A United States BM9CKX3 0.54 371,825 202,384.35
0.32 EHTH EHEALTH INC United States B1G0F83 6.56 30,399 199,417.44
0.26 CPSI COMPUTER PROGRAM United States 2872122 9.19 17,724 162,883.56
0.03 OTHER PAYABLE & RECEIVABLES United States 1.00 17,095 17,094.91
0.00 CASH United States 1.00 2,929 2,928.60
0.00 HONG KONG DOLLAR United States 0.13 4 0.51
0.00 TAIWAN DOLLAR United States 0.03 1 0.03
Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 01/31/24

Sector Weight (%)
Health Care 91.9
Financials 4.6
Consumer Discretionary 2.7
Information Technology 0.8

Source: AltaVista Research, LLC

Country Breakdown As of 01/31/24

Country Weight (%)
United States 87.1
China 4.4
Japan 3.2
Germany 2.5
Hong Kong 2.4
South Korea 0.5

Source: AltaVista Research, LLC

ETF Characteristics As of 02/29/24

Return on Equity 0.80%
Weighted Avg. Market Cap 9,694 M
2023 2024
Price-to-earnings -67.79 324.54
Price-to-book value 2.68 2.68

Source: AltaVista Research, LLC

ETF Risk Stats As of 01/31/24

Versus Beta
S&P 500 1.03
MSCI EAFE 1.03
MSCI Emg. Mkts 0.84
Standard Deviation 22.70%

Source: AltaVista Research, LLC

TERMS OF USE

Global X Brasil Gestora de Investimentos Ltda. (“Global X Brasil”) is an asset manager authorized by the Brazilian Securities and Exchange Commission (“CVM”), constituted in the form of CVM Resolution No. 21/2021. Investing involves risks. The material on this site is for informational purposes only and does not constitute investment advice, recommendation, offer or solicitation to buy or sell any securities, funds, or strategies to any person in any jurisdiction in which an offer, solicitation, purchase, or sale would be illegal under the securities laws of such jurisdiction. Opinions expressed here are subject to change without notice. Reliance upon the information contained in this material is at the sole discretion of the reader. No securities regulator has confirmed the accuracy of any information contained herein. Access to the information on this site or the use of the services or information provided herein is prohibited by any person or entity in any jurisdiction or country where such distribution or use is contrary to local law, rules, or regulation. Investment in index funds (ETFs) involves risks, including detachment from the benchmark index and related to the liquidity of shares in the secondary market. Investment funds managed by Global X Brasil use strategies that can result in significant equity losses for their quota holders. Global X Brasil, its partners and employees are exempt of responsibility for any damages resulting directly or indirectly from the use of the information contained on this website.

FOR EVALUATION OF THE PERFORMANCE OF AN INVESTMENT FUND, IT IS RECOMMENDED THE ANALYSIS OF AT LEAST 12 (TWELVE) MONTHS. INVESTMENT FUNDS DO NOT HAVE A GUARANTEE FROM THE ADMINISTRATOR, THE MANAGER, ANY INSURANCE MECHANISM OR CREDIT GUARANTEE FUND – FGC. INVESTMENTS IN FINANCIAL AND CAPITAL MARKETS ARE SUBJECT TO RISKS OF LOSS GREATER THAN THE TOTAL VALUE OF INVESTED CAPITAL. PAST PROFITABILITY DOES NOT REPRESENT A GUARANTEE OF FUTURE PROFITABILITY THE PROFITABILITY DISCLOSED IS NOT NET OF TAXES. READ THE PROSPECTUS, THE FORM OF COMPLEMENTARY INFORMATION, SHEET OF ESSENTIAL INFORMATION AND THE REGULATION BEFORE INVESTING. DESCRIPTION OF THE ANBIMA TYPE AVAILABLE IN THE FORM OF COMPLEMENTARY INFORMATION.

Back to Top